AbbVie (ABBV) Plans $7.5B Tender Offer

With earnings, AbbVie (NYSE: ABBV) said it plans to commence a tender offer to purchase for cash up to $7.5 billion in value of shares of its common stock through a modified "Dutch auction" tender offer at a specified price range to be determined. AbbVie expects to commence the tender offer as early as May 1, 2018.

The tender offer forms a part of AbbVie's $10 billion stock repurchase program announced on February 15, 2018.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
• Canaccord Starts L1 Group Ltd (L1G:AU) at Buy